Related Experiment Video
Updated: Aug 17, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes
Wajeh Y Qunibi1, Fadi Abouzahr, Mohammad R Mizani
1Department of Medicine, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas 78229-3900, USA. qunibi@uthscsa.edu
Insights
Cardiovascular calcification (CVC) is common in patients with chronic kidney disease (CKD) not on dialysis. Advanced CKD significantly increases the prevalence and severity of coronary and peripheral artery calcification (CAC and PAC).
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Cardiovascular calcification (CVC) is prevalent in end-stage renal disease patients on dialysis.
- CVC prevalence and severity are less understood in non-dialysis chronic kidney disease (CKD) patients.
- Diabetic patients with CKD are a key population to study for vascular calcification.
Purpose of the Study:
- To investigate the prevalence and severity of CVC in non-dialysis diabetic patients with varying stages of CKD.
- To assess the association between renal function and vascular calcification burden in predialysis CKD patients.
Main Methods:
- Fifty-eight non-dialyzed diabetic patients with CKD were enrolled.
- Patients were divided into early (CKD stages 1-2) and advanced (CKD stages 4-5) groups.
- Coronary artery calcification (CAC) was measured using ultrafast spiral computed tomography; peripheral artery calcification (PAC) was evaluated using plain x-ray.
Main Results:
- Prevalence of CAC and PAC was significantly higher in the advanced CKD group (73% vs. 38% and 85% vs. 35%, respectively).
- Median CAC scores were 18-fold greater in the advanced CKD group.
- A strong association was found between reduced renal function and increased CAC volume.
Conclusions:
- Coronary and peripheral artery calcification are common and severe in diabetic patients with predialysis CKD.
- Lower renal function levels correlate with a higher burden of vascular calcification in these patients.
- These findings highlight the importance of monitoring vascular calcification in non-dialysis CKD patients.
Background:
Cardiovascular calcification (CVC) is common and severe in patients with end-stage renal disease on dialysis. However, the prevalence and severity of CVC is less well documented in patients with chronic kidney disease (CKD) not yet on dialysis.
Methods:
Fifty-eight nondialyzed HA with type 2 diabetes and CKD were enrolled. They comprise 29 patients with stages 1 and 2 CKD (early CKD group) and 26 patients with stages 4 and 5 CKD (advanced CKD group). Coronary artery calcification (CAC) was measured by ultrafast spiral computed tomography, while peripheral artery calcification (PAC) was evaluated by plain x-ray of the chest, pelvis, thighs, and lower extremities.
Results:
The prevalence of CAC and PAC were significantly higher in the advanced CKD group compared to the early CKD group (73% vs. 38%; P < 0.01 and 85% vs. 35%; P < 0.0001, respectively). The median CAC scores were 18-fold greater in the advanced CKD group (138.9 vs. 7.8, respectively). By linear regression analysis, a strong association was found between the level of renal function and ln total volume of CAC.
Conclusion:
Our data indicate that CAC and PAC are common and severe in HA diabetic patients with CKD not previously treated with dialysis, calcium-based phosphate binders, or vitamin D analogues. Lower level of renal function is associated with increased burden of vascular calcification in predialysis patients with CKD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Diabetic Nephropathy
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Coronary Artery Disease I: Introduction

